Search Our Website:
Insights (2 out of 2 results)
Top 10 Investor Insights on Life Sciences Post-COVID-19
JUL 7 2020

nimble is also critical, as the trajectory of new COVID-19 cases appears far from settled. Additional Contributors: Steven Casey, Partner, eCTD Solutions; Elizabeth Minnigh, Shareholder, and Richard DiStefano, Shareholder, Buchanan Ingersoll & Rooney. For more cutting-edge perspectives on legal and business implications of COVID-19, visit our COVID-19 resource center. ...

Potential Adverse Inference Instruction for Unintended ESI Spoliation May Suggest Limitations of Recently Amended Rule 37(e)
OCT 24 2017

ny fact patterns are less clear cut. Rather, as another recent opinion noted, conduct leading to ESI loss may fall along a “spectrum” ranging from negligence to intentionality. See, e.g., Distefano v. Law Offices of Barbara H. Katsos, PC, 11-cv-2893, 2017 WL 1968278, at *8 (E.D.N.Y. May 10, 2017).3 The advisory committee notes approach would filter the gray facts on that spectrum throu...

News & Events (5 out of 5 results)
Life Sciences Executive Exchange Series Session Three - Finding Capital and Controlling Your Agreements
MAY 21 2021

In this series, designed for experienced pharma professionals and executives, Buchanan professionals will tackle critical issues to help you navigate the Pharma Product Lifecycle. In each session, we will dive into a specific phase of the lifecycle, provide attendees with the latest pharma updates and cover trends happening within the FDA and the industry in general. For the third session, "Finding Capital and Controlling Your Agreements" moderator, Rocky Rodriguez welcomes an esteemed set of panelists.  Richard DiStefano, Shareholder - Corporate, Buchanan Ingersoll and Rooney  Daniel Geffken, Founder and Managing Director, Danforth Advisors Joe Lee, Executive ...

Buchanan Ingersoll & Rooney Represents Medical Marijuana Client TerraVida in Sale
MAR 3 2021

to help TerraVida with this transaction,” said Joe Centeno, Shareholder and Co-Chair of Buchanan’s Labor & Employment section. “TerraVida has built a remarkable organization that is a market leader in Pennsylvania and will be a valuable addition to the Verano portfolio.” The Buchanan team included Brian North, Richard DiStefano, Shareholders in the Corporate section, Joe Centeno, John Warner, Shareholder in the Tax section, Andrew Giorgione, Shareholder in the Government Relations group, and Audrey Distler, Associate in the Corporate section....

Buchanan Ingersoll Makes Two New Additions in New York - New York Law Journal
NOV 3 2017

The New York Law Journal published "Buchanan Ingersoll Makes Two New Additions in New York," highlighting the recent hire of Richard DiStefano in our Corporate section and Marc Adler in our Intellectual Property section.The article speaks to the larger growth of our New York office and details Rich's aim to broaden the Corporate and Securities group and work with emerging companies as a part of Buchanan Labs, as well as Marc's role in expanding our patent and trade secret management services....

Buchanan Ingersoll Hires Blank Rome Transactional Atty - Law360
NOV 2 2017

Law360 wrote about Buchanan's recent hire of Richard DiStefano, highlighting his interest in Buchanan Labs in "Buchanan Ingersoll Hires Blank Rome Transactional Atty."...

Buchanan Ingersoll & Rooney Boosts Securities Practice with Richard DiStefano
OCT 30 2017

NEW YORK – October 30, 2017 – Buchanan Ingersoll & Rooney continues to expand its Corporate section, specifically its public company practice, with the addition of Richard DiStefano, a shareholder in the firm’s New York office. DiStefano works with public and private companies, advising on corporate and securities matters. His experience cuts across a variety of industries, including financial services, retail, marketing, media and entertainment, beverage, personal care, nutritional supplements and medical device businesses. “As we continue to add depth to our public company practice, we are delighted to have Rich as part of our team. Rich has a distinctive abili...